Belmont Global Advisors, Inc. - MEDGENICS INC ownership

MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 65 filers reported holding MEDGENICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Belmont Global Advisors, Inc. ownership history of MEDGENICS INC
ValueSharesWeighting
Q2 2016$111,000
-71.6%
20,000
-69.2%
0.11%
-78.9%
Q4 2015$391,000
-67.7%
65,000
-58.1%
0.51%
-75.4%
Q3 2015$1,212,000
+445.9%
155,000
+328.2%
2.06%
+736.6%
Q2 2015$222,000
-8.3%
36,200
+20.7%
0.25%0.0%
Q1 2015$242,000
+139.6%
30,000
+50.0%
0.25%
+146.0%
Q4 2014$101,000
-88.1%
20,000
-87.8%
0.10%
-85.0%
Q3 2014$848,000
-67.9%
163,347
-52.0%
0.66%
-65.1%
Q2 2014$2,642,000
+11.3%
340,0000.0%1.91%
-4.5%
Q1 2014$2,373,000
+20.0%
340,000
+3.0%
2.00%
+25.0%
Q4 2013$1,977,000330,0001.60%
Other shareholders
MEDGENICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,058,400$8,277,0004.07%
Belmont Global Advisors, Inc. 155,000$1,212,0002.06%
Broadfin Capital, LLC 1,545,306$12,084,0000.67%
CARL DOMINO INC 34,134$267,0000.21%
QVT Financial LP 267,608$2,093,0000.07%
WHITE PINE CAPITAL LLC 20,000$156,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 119,000$931,0000.02%
HYMAN CHARLES D 13,000$102,0000.02%
Kavar Capital Partners, LLC 1,500$11,0000.01%
Brick & Kyle, Associates 1,000$8,0000.01%
View complete list of MEDGENICS INC shareholders